These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29958524)

  • 1. Evaluation of Pgp (MDR1) immunohistochemistry in canine lymphoma - prognostic and clinical aspects.
    Vajdovich P; Koltai Z; Dékay V; Kungl K; Harnos A
    Acta Vet Hung; 2018 Jun; 66(2):309-328. PubMed ID: 29958524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.
    Lee JJ; Hughes CS; Fine RL; Page RL
    Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma.
    Rebhun RB; Lana SE; Ehrhart EJ; Charles JB; Thamm DH
    J Vet Intern Med; 2008; 22(4):989-95. PubMed ID: 18647159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
    Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
    Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
    J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic significance of histologic grade, pgp, and p53 expression in canine lymphoma.
    Dhaliwal RS; Kitchell BE; Ehrhart E; Valli VE; Dervisis NG
    J Am Anim Hosp Assoc; 2013; 49(3):175-84. PubMed ID: 23535752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of ABC transporter expression in canine multicentric lymphoma.
    Zandvliet M; Teske E; Schrickx JA; Mol JA
    Vet J; 2015 Aug; 205(2):263-71. PubMed ID: 25475167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
    Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
    Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of P-glycoprotein expression in feline lymphoma and correlation with clinical outcome.
    Brenn SH; Couto SS; Craft DM; Leung C; Bergman PJ
    Vet Comp Oncol; 2008 Sep; 6(3):201-11. PubMed ID: 19178680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results.
    Zandvliet M; Rutteman GR; Teske E
    Vet J; 2013 Sep; 197(3):656-61. PubMed ID: 23746872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
    Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
    Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of DNA methylation profiles of the CpG island of the ABCB1 gene in dogs with lymphoma.
    Tomiyasu H; Fujiwara-Igarashi A; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    Am J Vet Res; 2014 Sep; 75(9):835-41. PubMed ID: 25157887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
    Wang SL; Lee JJ; Liao AT
    Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
    Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
    Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.